» Articles » PMID: 31195746

Interference with Amyloid-β Nucleation by Transient Ligand Interaction

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2019 Jun 15
PMID 31195746
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Amyloid-β peptide (Aβ) is an intrinsically disordered protein (IDP) associated with Alzheimer's disease. The structural flexibility and aggregation propensity of Aβ pose major challenges for elucidating the interaction between Aβ monomers and ligands. All-D-peptides consisting solely of D-enantiomeric amino acid residues are interesting drug candidates that combine high binding specificity with high metabolic stability. Here we characterized the interaction between the 12-residue all-D-peptide D3 and Aβ42 monomers, and how the interaction influences Aβ42 aggregation. We demonstrate for the first time that D3 binds to Aβ42 monomers with submicromolar affinities. These two highly unstructured molecules are able to form complexes with 1:1 and other stoichiometries. Further, D3 at substoichiometric concentrations effectively slows down the β-sheet formation and Aβ42 fibrillation by modulating the nucleation process. The study provides new insights into the molecular mechanism of how D3 affects Aβ assemblies and contributes to our knowledge on the interaction between two IDPs.

Citing Articles

Glucosyl Platinum(II) Complexes Inhibit Aggregation of the C-Terminal Region of the Aβ Peptide.

La Manna S, Leone M, Iacobucci I, Annuziata A, Di Natale C, Lagreca E Inorg Chem. 2022; 61(8):3540-3552.

PMID: 35171608 PMC: 9951207. DOI: 10.1021/acs.inorgchem.1c03540.


Oral Treatment with RD2RD2 Impedes Development of Motoric Phenotype and Delays Symptom Onset in SOD1 Transgenic Mice.

Post J, Schaffrath A, Gering I, Hartwig S, Lehr S, Jon Shah N Int J Mol Sci. 2021; 22(13).

PMID: 34209129 PMC: 8269060. DOI: 10.3390/ijms22137066.


A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model.

Post J, Kogel V, Schaffrath A, Lohmann P, Jon Shah N, Langen K Molecules. 2021; 26(6).

PMID: 33805709 PMC: 7999518. DOI: 10.3390/molecules26061590.


Dreaming of a New World Where Alzheimer's Is a Treatable Disorder.

Catania M, Giaccone G, Salmona M, Tagliavini F, Di Fede G Front Aging Neurosci. 2019; 11:317.

PMID: 31803047 PMC: 6873113. DOI: 10.3389/fnagi.2019.00317.

References
1.
Olubiyi O, Strodel B . Structures of the amyloid β-peptides Aβ1-40 and Aβ1-42 as influenced by pH and a D-peptide. J Phys Chem B. 2012; 116(10):3280-91. DOI: 10.1021/jp2076337. View

2.
Kingsbury J, Laue T . Fluorescence-detected sedimentation in dilute and highly concentrated solutions. Methods Enzymol. 2011; 492:283-304. DOI: 10.1016/B978-0-12-381268-1.00021-5. View

3.
Gremer L, Scholzel D, Schenk C, Reinartz E, Labahn J, Ravelli R . Fibril structure of amyloid-β(1-42) by cryo-electron microscopy. Science. 2017; 358(6359):116-119. PMC: 6080689. DOI: 10.1126/science.aao2825. View

4.
Nick M, Wu Y, Schmidt N, Prusiner S, Stohr J, DeGrado W . A long-lived Aβ oligomer resistant to fibrillization. Biopolymers. 2018; 109(8):e23096. PMC: 6039285. DOI: 10.1002/bip.23096. View

5.
Wiesehan K, Buder K, Linke R, Patt S, Stoldt M, Unger E . Selection of D-amino-acid peptides that bind to Alzheimer's disease amyloid peptide abeta1-42 by mirror image phage display. Chembiochem. 2003; 4(8):748-53. DOI: 10.1002/cbic.200300631. View